Treating Tobacco Addiction: from Negligence to Excellence | Lung Cancer Nursing UK Skip to main content

Treating Tobacco Addiction: from Negligence to Excellence

Tuesday 25th May 2021, 17.30 - 18.30

In this webinar, Matthew Evison will provide an overview on the pathology of tobacco addiction, the need to medicalise this as a disease and the highly effective treatments it has. It will focus on the proactive role of the Lung Cancer CNS in treating this disease.

Our webinars are for healthcare professionals only.

Watch On Demand

Speakers

Matthew EvisonMatthew Evison

Dr Matthew Evison (MD MRCP) is a Consultant Chest Physician at Wythenshawe Hospital, Manchester University NHS Foundation Trust. He is a specialist in lung cancer, pleural disease and tobacco dependency treatment. Dr Evison has been part of the team at Wythenshawe Hospital that have delivered the RAPID Lung Cancer Pathway Programme (HSJ Award winners 2018), the Manchester Lung health Check Programme (BMJ Award winners 2019) and the CURE Project. He is the Clinical Director for Lung Cancer in Greater Manchester Cancer and the Clinical Lead for the Greater Manchester CURE Project, embedding tobacco dependency treatment across acute care trusts. He is a member of the British Thoracic Society Specialist Advisory Groups for Tobacco and Pleural and a member of the British Thoracic Oncology Group Steering Committee.


Peter BartonPeter Barton

LCNUK Committee member. After studying for his Nursing degree at the University of Manchester, Peter initially started his career as a nurse at Stepping Hill hospital in 2011 and gained his main experience on the acute medical wards. In 2015 whilst at Stepping Hill hospital Peter was appointed as a Macmillan Lung Cancer Nurse as a secondment and in 2016 moved to the Wythenshawe Hospital team where he continues his career in Lung Cancer Nursing. Peter has recently completed an MSc in Lung Cancer and he is also on the committee of the LGBTQ Network for Manchester Foundation Trust



We are grateful to our corporate supporters for their financial support which supports the core activities of the organisation and allows us to make services either freely available or at greatly reduced rates to its members.

Image
Amgen Oncology
Image
Lilly Oncology
Image
MSD

For more information, please read our Statement on Commercial Funding.

Speaker(s)